Baltimore-based Sisu Global Health has announced $200,000 in funding from the Abell Foundation to further progress of its medical device created to be used in the developing world.
{iframe}http://medcitynews.com/2016/04/sisu-global-health/{/iframe}
Sisu Global Health announces new funding for its Hemafuse blood recycling device – MedCity NewsMedCity News
Baltimore-based Sisu Global Health has announced $200,000 in funding from the Abell Foundation to further progress of its medical device created to be used in the developing world.
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
© 2025 BioHealth Innovation.
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.